Trials / Unknown
UnknownNCT02799446
Effect of Reslizumab in Chronic Rhinosinusitis
Efficacy of Reslizumab for the Treatment of Chronic Rhinosinusitis A Double Blind, Randomized, Placebo-controlled, Phase III Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Joshua S. Jacobs · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Reslizumab is effective for the treatment of chronic sinusitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Reslizumab | Reslizumab 3mg/kg intravenous (IV) |
| DRUG | Placebo | Matching Placebo intravenous (IV) |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
- First posted
- 2016-06-14
- Last updated
- 2018-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02799446. Inclusion in this directory is not an endorsement.